# Evaluation of a New Cardiac Biomarker Assay

Study · id `cardio:ct-nct01608100` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01608100](<https://clinicaltrials.gov/study/NCT01608100>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01608100

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1101 participants.

## Technical summary

Registry record NCT01608100. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-06 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2015-03-17.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 1101 participants (enrolled count; ClinicalTrials.gov record NCT01608100, source copy `cardio:ctgov-nct01608100-2015-03-17`, retrieved 2026-10-31)
- Start date: 2012-06 (registry gives no type) (ClinicalTrials.gov record NCT01608100, source copy `cardio:ctgov-nct01608100-2015-03-17`, retrieved 2026-10-31)
- Primary completion: 2014-08 (actual) (ClinicalTrials.gov record NCT01608100, source copy `cardio:ctgov-nct01608100-2015-03-17`, retrieved 2026-10-31)
- Completion: 2014-09 (actual) (ClinicalTrials.gov record NCT01608100, source copy `cardio:ctgov-nct01608100-2015-03-17`, retrieved 2026-10-31)
- Results first posted: 2015-03-17 (ClinicalTrials.gov record NCT01608100, source copy `cardio:ctgov-nct01608100-2015-03-17`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01608100, source copy `cardio:ctgov-nct01608100-2015-03-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01608100-2015-03-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of a New Cardiac Biomarker Assay
- Condition: Acute Coronary Syndrome
- Condition: Acute Myocardial Infarction
- Intervention (Device): ARCHITECT STAT High Sensitive Troponin I Assay
- Lead sponsor: Abbott Diagnostics Division
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)

## Provenance

Content hash: 6af7160abd5f68dde54bb4981ce6d37a293a415a85c916421db30195744a7db9
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
